Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2014

View Archived Issues

Discovery Laboratories awarded SBIR grant for aerosolized KL4-surfactant

Phase III topline results for Intarcia's ITCA-650 for type 2 diabetes

Biofrontera reports preliminary results from phase III trial of Ameluz

Novel prophylactic human cytomegalovirus vaccine shows promise in vivo

Phase I trial of lirilumab in combination with elotuzumab begins

Eleven Biotherapeutics reports topline data from phase II study of EBI-005

Prophylix Pharma to begin phase I/II trials of NAITgam for prevention of FNAIT

Preclinical activity of a novel long-lasting antimycotic echinocandin

Clinical results presented for the novel cell-based anti-HIV therapy, SB-728-T

IL-10-modified autologous dendritic cells administered to patients with multiple sclerosis

BMS selects NeurOp NMDA receptor modulator for development for depression

Oxford BioTherapeutics and Berlin Chemie/Menarini select second anticancer antibody-drug conjugate

Novel analgesic compounds synthesized at Esteve

IBI-20089 and ranibizumab combination is well tolerated in phase I trial in AMD

Santen confirms closing of asset purchase agreement with Merck & Co.

PEGPH-20 receives orphan drug designation for pancreatic cancer

Novel IRAK-4 inhibitors disclosed by Biogen Idec

FDA grants orphan drug status to chariSMA for spinal muscular atrophy

Treatment begins in phase II study of RPC-4046 for eosinophilic esophagitis

AbbVie divulges novel PDE10A inhibitors

U.S. investigators synthesize novel anti-C. difficile antibodies

Bristol-Myers Squibb reports new KCNA5 channel blockers for arrhythmia

BioMarin Pharmaceutical presents novel HDAC inhibitors

Novartis prepares new IDH inhibitors for cancer

Actimmune receives U.S. orphan drug designation for Friedreich's ataxia

Boehringer Ingelheim presents phase III results for linagliptin/pioglitazone FDC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...